Form 4: Omega Flex President Sells Shares Under 10b5-1 Plan

Omega Flex, Inc. President Edwin B. Moran reported the exercise of phantom stock and subsequent sale of 494 common shares.

Summary

• Edwin B. Moran, President and Director of Omega Flex, Inc. (OFLX), reported transactions on February 22, 2026.
• Moran exercised 494 units of phantom stock, which are economically equivalent to one share of common stock and settled for cash on a one-for-one basis.
• Concurrently, Moran disposed of 494 shares of Omega Flex common stock at a price of $37.55 per share.
• Following these transactions, Moran directly owns 0 shares of common stock.
• Moran indirectly holds 405 equivalent shares in the company's 401(k) plan, based on a statement as of December 31, 2025.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, typical for executive compensation and liquidity management, especially given the 10b5-1 plan disclosure.

Positives

• The transaction was executed under a Rule 10b5-1 plan, indicating a pre-scheduled sale rather than a discretionary one based on new, non-public information.

Negatives

• An insider sale, even if pre-planned, can sometimes be perceived by the market as a lack of confidence, though the 10b5-1 plan mitigates this perception.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for insiders, and a sale under a 10b5-1 plan indicates a pre-scheduled transaction for liquidity or diversification purposes rather than a reaction to new, material information. Such transactions are common for executives managing their compensation and equity holdings.

Stakeholder Impact

• Shareholders: A minor insider sale, though pre-planned, could be perceived with slight caution, but the small volume and 10b5-1 plan mitigate any significant negative impact.

Key Dates

Recommendation

The reported transaction is a routine insider sale of phantom stock and equivalent common shares, likely pre-scheduled under a Rule 10b5-1 plan. This type of transaction generally does not indicate a significant shift in company fundamentals or management's outlook, thus a 'hold' recommendation is appropriate.

Keywords

Omega Flex, OFLX, Form 4, insider trading, stock sale, phantom stock, executive compensation, Edwin B. Moran, 10b5-1 plan